Compare · BIO vs VIVO
BIO vs VIVO
Side-by-side comparison of Bio-Rad Laboratories Inc. (BIO) and VivoPower PLC (VIVO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BIO operates in Health Care, while VIVO operates in Utilities - the two are in different parts of the market.
- BIO is the larger of the two at $9.95B, about 178.0x VIVO ($55.9M).
- VIVO has been more active in the news (10 items in the past 4 weeks vs 2 for BIO).
- BIO has more recent analyst coverage (12 ratings vs 3 for VIVO).
- Company
- Bio-Rad Laboratories Inc.
- VivoPower PLC
- Price
- -
- -
- Market cap
- $9.95B
- $55.9M
- 1M return
- -
- -23.62%
- 1Y return
- -
- -27.61%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Power Generation
- Exchange
- NYSE
- NASDAQ
- IPO
- 1980
- News (4w)
- 2
- 10
- Recent ratings
- 12
- 3
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
VivoPower PLC
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare and PediaStat brands; and urea breath testing for H. pylori under the BreathID brand. This segment also offers gastrointestinal assays, including tests for C. difficile, H. pylori, and certain foodborne pathogens; respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry assays for testing elevated levels of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. The company has a strategic collaboration with DiaSorin Inc. to sell H. pylori tests. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Latest BIO
- Bio-Rad Reports Third-Quarter 2026 Financial Results
- Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference
- Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
- Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum
- Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference
- IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
- Bio-Rad Reports Second-Quarter 2026 Financial Results
- Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026
- RBC Capital Mkts resumed coverage on Bio-Rad Labs with a new price target
- Bio-Rad to Participate in Upcoming Investor Conferences
Latest VIVO
- SEC Form 6-K filed by VivoPower PLC
- Amendment: SEC Form SCHEDULE 13D/A filed by VivoPower PLC
- Chairman & CEO Kevin Chin bought $553,910 worth of Class A Ordinary Shares (287,000 units at $1.93) (SEC Form 4)
- SEC Form 6-K filed by VivoPower PLC
- VivoPower’s Tembo Launches KOVA, its 4WD All-Electric Dual-Motor Platform and Utility Pickup Truck
- VivoPower Confirms Strategic Update and Results Conference Call Moved to November 16, 2026
- SEC Form 6-K filed by VivoPower PLC
- VivoPower Reports Unaudited First Quarter Fiscal Year 2027 Results with Revenue of US$6.8 Million, Net Profit of US$0.6 Million and Positive Operating Cash Flow of US$2.1 Million
- VivoPower Reports FY2026 Results Including a Partial-Period Contribution from Mo i Rana Data Center
- SEC Form 20-F filed by VivoPower PLC